[A special type of discogenic low back pain: normal signal intensity of magnetic resonance imaging with abnormal discography].

OBJECTIVE: To report a group of special patients showing a normal signal intensity of MRI with a positive discography and discuss its pathogenesis and clinical significance. METHODS: From August 2003 to November 2008, 288 patients with chronic low back pain were treated. Of these patients, 12 showed a normal intensity signal of MRI in lumbar intervertebral discs with a positive discography. There were 7 males and 5 females aged 20 - 44 years with an average of 29.6 years. The duration of disease was 8 months to 3 years with an average of 1.8 years. Dallas CT grading method was used for assessing the degree of annular disruption. RESULTS: Of these 12 patients, 33 lumbar discs underwent discography. Twelve discs in 12 patients showed annular disruption and low back pain reproduction. Among 12 painful discs, 3 showed grade 2 annular disruption and 9 showed grade 3 annular disruption. CONCLUSION: Patients who are refractory to conservative care and have normal signal intensity in lumbar disc MRI and who are suggested as discogenic origin and might need further treatment such as minimal invasive surgery or lumbar interbody fusion should still be examined by discography.

[Natural history and prognosis of discogenic low back pain].

OBJECTIVE: To understand the natural history and prognosis of patients with discogenic low back pain so as to offer a better guide on its clinical treatment. METHODS: From December 2003 to November 2004, we consecutively hospitalized 72 patients with discogenic low back pain diagnosed by lumbar discography. These patients were randomized into two groups. One group (n = 36) received an intradiscal methylene blue (MB) injection immediately after discography while another group (n = 36) received a placebo. Both Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) were used to assess the back pain symptoms and the lumbar function respectively during a 4-year follow-up period. RESULTS: In total, 32 of 36 patients who received a placebo injection underwent a 4-year follow-up. Of these patients, 4 cases (12.5%) had their low back pain symptoms alleviated, 1 case (3.1%) slightly improved, 3 cases (9.4%) aggravated and 22 cases (68.8%) had no change in symptoms. According to VAS and ODI scores taken at different time points, these two scores gradually decreased over time; however, no statistical significances were found (VAS: F = 3.049, P > 0.05; ODI: F = 2. 272, P > 0.05). CONCLUSION: The disease course of discogenic low back pain is chronic and persistent so that its symptoms show no improvement over time.